title: Response and Adverse Effects of Nilotinib in Imatinib-Resistant Chronic Myeloid Leukemia Patients: Data From a Developing Country.
authors.affiliation: Department of Hematology, The Aga Khan University and Hospital, Karachi, Pakistan.
authors.forename: Shabneez
authors.initials: S
authors.lastname: Hussain
authors.affiliation: Department of Hematology, The Aga Khan University and Hospital, Karachi, Pakistan.
authors.forename: Usman
authors.initials: U
authors.lastname: Shaikh
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D011743:Pyrimidines